MARKET

CLLS

CLLS

Cellectis
NASDAQ
3.570
+0.070
+2.00%
After Hours: 3.400 -0.17 -4.76% 16:32 02/06 EST
OPEN
3.660
PREV CLOSE
3.500
HIGH
3.660
LOW
3.490
VOLUME
18.80K
TURNOVER
--
52 WEEK HIGH
5.48
52 WEEK LOW
1.100
MARKET CAP
258.20M
P/E (TTM)
-20.3767
1D
5D
1M
3M
1Y
5Y
1D
Monthly information on share capital and company voting rights
Barchart · 3d ago
Weekly Report: what happened at CLLS last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at CLLS last week (0119-0123)?
Weekly Report · 01/26 09:36
Weekly Report: what happened at CLLS last week (0112-0116)?
Weekly Report · 01/19 09:40
Wells Fargo Reaffirms Their Hold Rating on Cellectis SA (CLLS)
TipRanks · 01/14 06:25
Weekly Report: what happened at CLLS last week (0105-0109)?
Weekly Report · 01/12 09:39
Cellectis SA Showcases Leadership in Gene Editing and Allogeneic CAR-T Pipeline in New Corporate Presentation
Reuters · 01/09 14:06
Cellectis Sets 2026 Clinical Milestones and Extends Cash Runway Into H2 2027
TipRanks · 01/08 21:57
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.